Background: Few valid, disease-specific measures of health-related quality of life (HRQOL) capture the spectrum of symptoms associated with Huntington's
Introduction
Huntington's disease (HD) is an autosomal-dominant neurodegenerative disease caused by a CAG trinucleotide repeat expansion in the huntingtin gene on the short side of chromosome 4. HD is an insidious, progressive disorder that causes deficits in the symptom triad of cognitive, behavioral, and motor functioning. 1, 2 Symptoms gradually appear and worsen over time, leading to a clinical diagnosis of HD (currently based on unequivocal motor symptoms) often when affected individuals reach their mid-40s. Death occurs approximately 20 years after clinical diagnosis. 1 Coping with the progressive symptoms of the disease obviously affects an individual's health-related quality of life (HRQOL), a multidimensional construct used to determine the impacts of HD and its symptoms on emotional, cognitive, social, and physical well-being. 3 Several qualitative studies [4] [5] [6] [7] have examined HRQOL in individuals with HD by employing either semi-structured interviews or focus groups. Three semi-structured interview studies identified that concerns with physical, emotional, cognitive, social, and day-to-day functioning (including driving ability, interactions with others, household chores, conversing on the telephone, shopping, managing finances, ability to work, and cooking) had a significant impact on HRQOL. [4] [5] [6] Similarly, a focus group study provided support for five general HRQOL themes: emotional health (anxiety/fear, stigma, anger, psychiatric/behavioral changes, positive psychological function, resilience, and depression); social participation (interpersonal relationships, leisure, vocation, and independence/autonomy); physical/ mental health (gene testing, involuntary movements/chorea, mobility/ambulation, speech and swallowing difficulties, medications, health promotion, upper extremities, and weight loss); cognitive health (learning/memory, executive function, and communication/comprehension); and end-of-life issues (planning, interactions with others with HD, forward comparison). 7 Collectively, these studies highlight the multifaceted areas of HRQOL affected in individuals with HD. Many quantitative studies have also examined generic (not HDspecific) measures of HRQOL in HD, most using a single instrument. 5, [8] [9] [10] [11] [12] [13] [14] [15] [16] However, generic HRQOL instruments do not fully capture the triad of symptoms characteristic of HD, nor are they sensitive to change over time, which requires a more sensitive HRQOL assessment in this population.
To address these shortcomings, two instruments have been recently developed that target HD-specific HRQOL issues, the Huntington Quality of Life Instrument (H-QoL-I) 17 and the Huntington's Disease
Health-Related Quality of Life questionnaire (HDQoL). 17, 18 The H-QoL-I 17 is an 11-item self-report instrument examining three HRQOL dimensions: Motor Functioning, Psychology, and Socializing. The HDQoL 18 is a 40-item self-report instrument designed to evaluate six subdomains: Cognitive, Hopes and Worries, Services, Physical and Functional, Mood State, and Self and Vitality. The initial publication for the H-QoL-I indicates it has acceptable internal consistency (Cronbach's alpha.0.84), as well as satisfactory construct, discriminant, and external validity. 17 Similarly, the initial publication on the HDQoL indicates high reliability, stability, and internal consistency, good unidimensionality, and good construct validity. 18 However, these findings have not been replicated in independent samples, and neither instrument has been examined over time. The H-QoL-I is also limited by its narrow scope, as it only evaluates two of the three symptom domains characteristic of HD (motor and behavioral/emotional).
Although the HDQoL covers a wide range of HRQOL items, none are chorea-specific. The HDQoL also takes approximately 20 minutes to complete, which is acceptable in a research context, but might be difficult to administer in a clinical setting.
The purpose of the current study was to develop and validate a new instrument of HRQOL that 1) is specific to HD, 2) assesses fully the triad of symptoms characteristic of HD, and 3) can be administered in a clinical or research setting.
Methods
The development of the framework and content for the new HDspecific HRQOL instrument (HD-PRO-TRIAD TM ) has been fully described elsewhere. 4 23 and from Traumatic Brain Injury-QOL. 20, 21 Motor-related items were considered from the HDQLIFE item banks 7 and from the FACIT 22 system. After selecting and content matching available items with patient, caregiver, and provider perspectives, we drafted a preliminary instrument that was then cognitively tested in 10 individuals with HD. 4 The resulting HD-PRO-TRIAD TM (Version 1), consisting of 47 items, was administered to 172 participants (132 individuals with HD and 40 caregivers) for psychometric testing. These data were used to determine internal consistency, construct validity with existing HRQOL measures, and determine consistency between individuals with HD and their caregivers of HD-PRO-TRIAD TM . This process is summarized in Figure 1 .
Individual phone-based interviews with HD patients and caregivers
We conducted individual, semi-structured phone-based interviews with 15 individuals with HD and 16 HD caregivers. Six pairs of participants were patient-caregiver dyads. Audio recordings and notes were taken during individual interviews, which were transcribed and analyzed via NVivo 9.0 (QSR International Pty Ltd, Doncaster, Australia), a qualitative data analysis and management software package. Detailed results from the phone-based interviews are published in Victorson et al. 4 Content of the individual phone-based interviews was synthesized into a hierarchical domain framework, which was used to identify HD-specific HRQOL themes and dimensions. Items were developed to reflect three domains of HRQOL: cognition, emotional/behavioral, and motor functioning. This triad provided the basis for the item selection process.
HD-PRO-TRIAD TM content selection process
Cognitive functioning items. The phone-based interviews indicated that both individuals with HD and their caregivers expressed concerns with cognition, including difficulties with executive functioning, memory, and attention concentration. These concepts are captured by the Neuro-QOL Cognition item banks 24 and the TBI-QOL Cognition items. 20, 21 Therefore, 31 Neuro-QOL Cognition items (13 Executive Function and 18 General Concerns) and 32 TBI-QOL items were included for consideration in the development of this measure.
Emotional/behavioral functioning items. The phone-based interviews also highlighted concerns with emotional/behavioral functioning including anger, depression, anxiety, and disinhibition, as well as concepts captured by the Emotional and Behavioral Dyscontrol item bank from the Neuro-QOL. 24 Therefore, all 18 Neuro-QOL Emotional and Behavioral Dyscontrol items were included for consideration in development of this domain.
Motor functioning items. Furthermore, interview data highlighted concerns with motor functioning, especially with regard to chorea. To this end, we maintained the linkage to an HD-specific extension of the Neuro-QOL system on motor functioning, which is also currently under development. 25 As such, we determined that the HDQLIFE chorea items would be considered for inclusion in this measure, in addition to other motor items from FACIT.
22
Reading level and translations reviews. EuroQOL 5D. The EuroQOL 5D (EQ-5D) 27 is a five-item, standardized, self-report instrument designed to evaluate general health status (mobility, self-care, usual activities, pain/discomfort, anxiety/depression). It was scored from 0 to 1, with greater scores representing better QOL. physical scales were assessed in this study. For each scale, the SF-12 was scored from 0 to 100, with greater scores indicating better QOL. designed to evaluate HRQOL. The 10-item PROMIS Global Health instrument yields two summary scores -Physical Health and Mental Health. The PROMIS Global Health measures were scored according to the PROMIS scoring algorithm. The T-score metric for all PROMIS measures has a mean of 50 and SD of 10.
Self-reported functional capacity. The Unified Huntington's Disease Rating Scale (UHDRS) Total Functional Capacity (TFC) Scale, designed as a clinician-administered and rated scale, 31 was modified to capture self-reported functional capacity (Appendix 1). This modified self-report measure assessed functional capacity across five domains: Occupation, Finances, Domestic Chores, Activities of Daily Living (ADL), and Requirements for Unskilled or Skilled Care. Self-reported functional capacity was computed as a sum of the scores for the five domains (each ranging from 0 to 2 or 0 to 3), for a total score of 13, with greater scores indicating better functioning.
Self-reported functional independence. We modified the UHDRS Independence Scale (a clinician-rated scale) to be administered as a self-report measure designed to evaluate functional independence (Appendix 2). 32 The scoring criteria for clinicians provided the anchors for a 10-item scale assessing functional independence. Scores range from 1 to 10, with greater scores indicating lesser functional independence.
As referenced above, all items included in the HD-PRO-TRIAD were existing items selected from either the Neuro-QOL/PROMIS, TBI-QOL, or HDQLIFE measurement systems. Measures selected from PROMIS/Neuro-QOL for validation purposes did not include any overlap in items, as both measurement systems include multiple assessments across several different domains of functioning. (Table 2) . One hundred and twenty-five of the HD individuals were recruited through OP4G, and seven were recruited at the 2012 HDSA annual meeting. Twenty-five caregivers were recruited through OP4G, and 15 were recruited at the HDSA meeting. Demographics did not vary notably between recruitment sources. Sixty-five percent of individuals with HD reported a positive gene test, with an average self-reported CAG repeat length of 44. Average self-reported time since HD diagnosis was 5 years, with individuals reporting the presence of motor symptoms for an average of 6 years. Most individuals with HD reported that a parent had HD (55% paternal and 23% maternal). Most individuals selfreported their health statuses as good (37%), very good (19%), or excellent (5%).
Statistical analysis
Caregivers. The 40 caregivers examined had an average age of 44 years and were primarily white and female (Table 1) . Slightly more than 50% of caregivers were caring for spouses or partners. The remaining caregivers were caring for other family members (28%), HD Neuro-QOL scores were converted to T-scores based on a T-score metric, with a mean of 50 and SD of 10. For Neuro-QOL Anxiety and Depression, a greater T-score represents worse functionality, whereas in Neuro-QOL, Lower Extremity Function, Upper Extremity Function and Ability to Participate in Social Roles, a greater T-score represents better functionality. 4 PROMIS Global Mental Health and Physical Health scores were converted to T-scores based on a T-score metric, with a mean of 50 and SD of 10, with greater T-scores representing better functionality. 5 SF-12 Mental and Physical score range is 0-100, with greater scores representing better functionality. 6 EQ-5D score range is 0-1, with greater scores representing better functionality. 7 UHDRS TFC score range is 0-13, with greater scores representing better functionality. 
Descriptive statistics
The mean HD-PRO-TRIAD TM scores for individuals with HD based on patient and caregiver reports were similar. Based on patient reports, the mean scores for the three Cognition, Emotional and Behavioral Dyscontrol, and Motor Function domains were 3.2 (range, 1.0-5.0; SD, 1.1), 2.7 (range, 1.0-5.0; SD, 1.0), and 2.9 (range, 1.0-4.8; SD, 1.0), respectively. The total mean score for the overall HD-PRO-TRIAD TM instrument was 8.8 (Table 2) . Descriptive statistics for the other HRQOL instruments are also presented in Table 2 . Scores indicated that individuals with HD reported emotional functioning at degrees comparable to the general population (e.g., Neuro-QOL and PROMIS emotional scores were within 1 SD of the population mean of 50). However, degrees of physical functioning were lower than that of the general population (as indicated by all but one physical functioning score $1 SD below the mean).
Internal consistency
Internal consistency was excellent for all domains and the overall HD-PRO-TRIAD TM for both individuals with HD and caregivers (all Cronbach's alphas .0.95). In addition, item-total correlations ranged from 0.54 to 0.90 for individuals with HD, and 0.43 to 0.94 for caregivers. Likewise, inter-item correlations ranged from 0.14 to 0.88 for individuals with HD, and 20.14 to 0.90 for caregivers (Table 3) .
Convergent and divergent validity
Strong evidence supports both convergent and divergent validity for the three domains, as well as the overall HD-PRO-TRIAD TM instrument. In general, correlations were moderate to strong in the HD patient sample ( Table 4 
Consistency between caregiver proxy and HD patient self-report measures
Analysis of the data collected from the 29 HD patient-caregiver dyads indicates substantial consistency between caregiver proxy and HD patient self-reports. All intra-class correlations for the three domains and the overall HD-PRO-TRIAD TM instrument were .0.90. There are often discrepancies between what individuals with HD and their caregivers report to treating physicians. However, the HD-PRO-TRIAD TM proxy report and HD patient report were found to be highly consistent, in sharp contrast with other HD research of caregiver dyads that failed to find such a relationship. 10 The consistency between individuals with HD and their caregivers in our study suggests that HD-PRO-TRIAD TM may have utility in evaluating HRQOL for individuals with HD that may be unable to complete these measures themselves.
The HD-PRO-TRIAD TM includes 47 items (14 Cognition, 14
Emotional and Behavioral Dyscontrol, 19 Motor Function) and was developed to be easily administered and scored in both clinical and research settings. The intent of the authors is to have this instrument publically available for use to clinicians and researchers via an online domain. This measure is designed to capture PROs for individuals with HD. However, there is much discussion in the HD community about an individual's ability to provide reliable self-report data during the later phases of the disease, when both cognitive problems and anosognosia are common. [33] [34] [35] To this end, the general consensus is that self-report measures, by themselves, only capture one component of the clinical picture. Input from providers, caregivers, family members, and patients themselves is needed to provide a full clinical picture. Therefore, while PROs are an essential component of the clinical picture, they should be used in conjunction with both clinician and family-rated measures to build a complete clinical picture. Taken together, the HD-PRO-TRIAD TM captures the triad of symptoms characteristic of HD. While these findings highlight the initial reliability and validity of HD-PRO-TRIAD TM , future work in other HD patient samples is needed to fully understand both the sensitivity and the strengths and weaknesses of this instrument. Future work is needed to examine the relationship of these items to objective assessments of emotional, motor, and cognitive function and further refine this instrument by selecting the most sensitive items, allowing quick administration of HD-PRO-TRIAD TM . In addition, the use of the instrument in the context of an interventional trial still needs to be completed. We acknowledge the limitations of this study. First, data were collected via an online panel. Therefore, patient clinical characteristics, including diagnoses, gene testing, years since diagnosis, and years with symptoms, were self-reported and were not independently verified. Indeed, this was a convenience sample rather than a clinical study sample of HD patients. Second, we were only able to solicit selfreported estimates of disease stage, functional ability, and independence (rather than more typically used clinician-rated scales). Future work is required to evaluate the relationship between the self-report and clinician-rated versions of these scales. Third, while internal consistency was excellent, as indicated by Cronbach's alpha values greater than 0.95, we note that excessively high internal consistency may suggest item redundancy. 36, 37 That is, the items' content may be too narrow, with some not necessarily contributing incremental additional information. While there are no standard cutoffs for optimal internal consistency, it has been suggested that coefficient alphas of at least 0.80 are considered sufficient, and limiting items to no more than 35 for broad constructs (e.g., cognition, emotional/ behavioral dysfunction, and motor function) could reduce the risk of redundancy. 37 Nonetheless, item factor analysis should be explored in future analyses to assess the need for further item reduction. Both HD individuals and caregivers were instructed to take the online instruments separately, on their own. During the recruitment of participants at the HDSA meeting, HD individuals and caregivers were also reminded orally that the survey needed to be filled out separately and that HD individuals needed to be capable of filling out the forms without assistance, as noted in the eligibility criteria. However, we were not able to assess the extent to which such instructions were followed, and that HD individuals and caregivers did not share information. This is a fourth limitation of the study.
A final limitation is that the current study enrolled individuals with HD who were able to independently complete online panel testing. Therefore, application of the results may be limited to a greaterfunctioning HD patient sample. Indeed, our patient sample was a very well-educated group of fairly high-functioning individuals. This limits the generalizability of our results at this time. In the future, this instrument will also be evaluated for more moderate and more severe individuals with HD who require 24-hour supervision. This instrument, as with other HRQOL measures, is not appropriate for nonverbal individuals. The validity of this instrument in individuals with significant psychiatric issues, behavioral dyscontrol, or advanced dementia will also need to be determined.
Since we found that the caregiver proxy measures are well-correlated with the HD patient measures, the HD- PRO The following are questions on levels of functioning in the domains of occupation, finances, domestic chores, activities of daily living, and requirements for unskilled or skilled care. For each question, please indicate the answer choice that best describes the ability of the person with Huntington's disease whom you care for (i.e., as the care receiver) to accomplish the tasks described given his/her current Huntington's disease condition. In situations where the care receiver has not performed a certain task to allow for your observation, please estimate his/her ability to conduct such a task.
[UHDRS_occupation] Is the care receiver able to work? 05No, he/she is unable to work 15Yes, but he/she can only work part-time doing tasks that are less complicated than his/her usual work 25Yes, but he/she needs special accommodations to get his/her work done 35Yes, he/she can work normally with no accommodations needed
[UHDRS_finances] Is the care receiver able to manage his/her own finances? 05No, he/she is unable to manage his/her own finances independently 15Yes, but with major assistance from another person/people 25Yes, but with slight assistance from another person/ people 35Yes, he/she can to manage finances independently without assistance The following are questions on levels of functioning in the domains of occupation, finances, domestic chores, activities of daily living, and requirements for unskilled or skilled care. For each question, please indicate the answer choice that best describes your ability to accomplish the tasks described given your current Huntington's disease condition.
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